Standard BioTools Long Term Debt 2010-2025 | LAB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Standard BioTools long term debt from 2010 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Standard BioTools long term debt from 2010 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$45.6B
Doximity (DOCS)	$11.7B
Hims & Hers Health (HIMS)	$11.3B
Tempus AI (TEM)	$9.7B
IRhythm Technologies (IRTC)	$4.3B
Inspire Medical Systems (INSP)	$3.8B
Hinge Health (HNGE)	$3.6B
Privia Health (PRVA)	$2.5B
Enovis (ENOV)	$1.8B
Phreesia (PHR)	$1.6B
Clover Health Investments (CLOV)	$1.5B
10x Genomics (TXG)	$1.5B
Schrodinger (SDGR)	$1.5B
Azenta (AZTA)	$1.5B
Evolent Health (EVH)	$1.3B
Omnicell (OMCL)	$1.3B
Claritev (CTEV)	$717M
Fulgent Genetics (FLGT)	$550M
Veradigm (MDRX)	$536M
Butterfly Network (BFLY)	$435M
Talkspace (TALK)	$420M
TruBridge (TBRG)	$321M
Outset Medical (OM)	$320M
Nyxoah SA (NYXH)	$270M
Health Catalyst (HCAT)	$260M
SOPHiA GENETICS SA (SOPH)	$231M
CapsoVision (CV)	$213M
Zepp Health (ZEPP)	$203M
KORU Medical Systems (KRMD)	$136M
American Well (AMWL)	$125M